Virbac Advances Senior Cat Care Through International Veterinary Symposium in Edinburgh

International symposium in Edinburgh highlights early diagnosis, multimorbidity management, nutrition and treatment compliance in ageing cats

Virbac has convened nearly 100 feline-medicine specialists from Europe, the United States and Australia at an international symposium in Edinburgh, Scotland, to discuss the evolving clinical challenges associated with ageing cats.

Announced on 1 October 2026, the initiative focuses on improving veterinary approaches to senior-cat health through earlier diagnosis, integrated disease management, nutritional support and treatment strategies designed to reduce the burden of daily care.

The symposium reflects a broader shift in companion-animal healthcare, where increasing pet longevity is creating demand for more comprehensive management of chronic conditions and age-related health challenges.

Ageing cats: the growing challenge of multimorbidity

Longer feline lifespans are accompanied by a greater prevalence of chronic and concurrent health conditions.

Virbac’s announcement highlighted several figures to illustrate the clinical and caregiver challenges associated with senior cats:

These figures draw on a mixture of published research, consensus sources and company-generated field data or surveys. They should be interpreted according to their original populations, study methods and definitions rather than as universal prevalence estimates.

The clinical challenge extends beyond individual diseases. Older cats may experience combinations of kidney disease, thyroid dysfunction, hypertension, degenerative joint disease and mobility impairment.

Because cats can conceal signs of pain or illness, veterinary teams face the additional challenge of detecting disease before it significantly affects quality of life.

Five areas of clinical focus

The Edinburgh symposium brought together internal medicine specialists, endocrinologists and clinicians to examine practical improvements in feline geriatrics.

1. Early diagnosis

In-clinic rapid diagnostic tools can support the identification of diseases during asymptomatic or early stages, potentially allowing more timely clinical intervention.

2. Endocrinology and treatment administration

Adapted formulations and simplified administration approaches can help address treatment-compliance challenges, particularly among cats requiring long-term medication.

3. Renal care and nutrition

The symposium explored nutritional strategies for cats with kidney disease, including approaches combining renal support, joint comfort and simplified delivery of treatment through food.

4. Mobility and joint health

Age-related mobility impairment and osteoarthritis require attention to pain management, targeted joint support and maintaining everyday activity.

5. Preventive healthcare

Tailored preventive protocols can support immunity, overall wellbeing and monitoring as cats progress through their senior years.

Reducing treatment burden and preserving the human-animal bond

A central theme of Virbac’s initiative is the relationship between clinical effectiveness and the practicality of daily treatment. Long-term medication schedules, difficult administration and repeated veterinary interventions can affect both pet owners and their animals.

For the veterinary industry, treatment compliance is therefore not simply an operational issue. It is a potential driver of product formulation, delivery-system innovation, nutritional product development and veterinary service design.

Virbac’s approach emphasizes solutions that integrate clinical care into everyday routines, potentially reducing stress for both cats and their caregivers.

Industry implications: feline geriatrics as an integrated market opportunity

The ageing companion-animal population creates opportunities across several interconnected segments:

• Veterinary diagnostics for early disease detection.

• Prescription and specialized nutrition for renal and metabolic conditions.

• Chronic-disease pharmaceuticals and improved drug-delivery formulations.

• Joint-health and mobility-support products.

• Preventive veterinary services and long-term disease monitoring.

• Veterinary education and clinical decision-support initiatives.

For animal-health companies, the strategic opportunity extends beyond launching individual products. Integrated solutions that combine diagnostics, nutrition, pharmaceuticals and professional education may help address the complexity of feline multimorbidity.

Virbac’s symposium also reinforces the importance of veterinarian engagement as a component of companion-animal healthcare strategy. The commercial impact of the initiative has not been quantified, and the announcement does not report new product launches or clinical trial outcomes.

Industry takeaway: Virbac is positioning senior-cat care around integrated disease management, early detection and reduced treatment burden, reflecting the growing clinical and commercial importance of feline geriatrics.